Reactive Oxygen Species-Responsive Gel-Based Microneedle Patches for Prolonged and Intelligent Psoriasis Management

Psoriasis is an inflammatory skin disease. Microneedle (MN) patches can improve psoriasis treatment outcomes by increasing local drug content in the skin. As psoriasis frequently relapses, developing intelligent MN-based drug delivery systems with prolonged therapeutic drug levels and improved treatment efficiency is of great significance. Here, we designed detachable H2O2-responsive gel-based MN patches containing methotrexate (MTX) and epigallocatechin gallate (EGCG) by using EGCG as both cross-linkers for needle-composited materials and anti-inflammatory drugs. The gel-based MNs had dual-mode drug release kinetics, which quickly released MTX diffusively and sustainably released EGCG in an H2O2-responsive way. Compared with dissolving MNs, the gel-based MNs extended skin retention of EGCG, leading to prolonged reactive oxygen species (ROS) scavenging effects. The ROS-responsive MN patches that transdermally delivered antiproliferative and anti-inflammatory drugs improved treatment outcomes in both psoriasis-like and prophylactic psoriasis-like animal models.

Automated summary

This study developed detachable H2O2-responsive gel-based microneedle (MN) patches containing methotrexate (MTX) and epigallocatechin gallate (EGCG), which showed dual-mode drug release kinetics and improved treatment outcomes in psoriasis-like animal models. The gel-based MNs extended skin retention of EGCG, leading to prolonged ROS scavenging effects. These ROS-responsive MN patches delivered antiproliferative and anti-inflammatory drugs transdermally, demonstrating potential for improved psoriasis treatment.